AcelRx Pharmaceuticals, Inc announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company’s proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route. ARX-01 offers a non-invasive alternative to intravenous patient-controlled analgesia (IV PCA) for the management of acute post-operative pain in the hospital setting.
Read more about AcelRx Announces Successful Completion Of End-of-Phase 2 Meeting On ARX-01, Sufentanil NanoTab PCA System For Post-Operative Pain Management
Biofield therapies, which claim to use subtle energy to stimulate the body’s healing process, are promising complementary interventions for reducing the intensity of pain in a number of conditions, reducing anxiety for hospitalized patients and reducing agitated behaviors in dementia, over and above what standard treatments can achieve. However, longer-term effects are less clear. Dr. Shamini Jain, from the UCLA Division of Cancer Prevention and Control Research, and Dr.
Read more about New Study Reviews Science Behind Efficacy Of Biofield Therapies – Reiki, Therapeutic Touch And Healing Touch
An f1000 evaluation examines how Pain Relief improves greatly when the sufferer can actually see the area where the pain is occurring. In an Anglo-Italian study, thirty healthy subjects were invited to look at either their own hand, the experimenter’s hand, or an object, while their hand was subjected to laser-induced pain.
Read more about New Hope For Chronic Pain Sufferers
Researchers from Tufts University School of medicine have determined that patients over 65 years of age with knee osteoarthritis (OA) who engage in regular Tai Chi exercise improve physical function and experience less pain. Tai Chi (Chuan) is a traditional style of Chinese martial arts that features slow, rhythmic movements to induce mental relaxation and enhance balance, strength, flexibility, and self-efficacy.
Read more about Tai Chi Exercise Reduces Knee Osteoarthritis Pain In The Elderly
Less pain during injections for wrinkle-fighting facial fillers. Less swelling afterward. Less time in the office waiting for anesthesia to take effect. These and other benefits of a new injection technique that UT Southwestern Medical Center plastic surgeons are helping pioneer are outlined in the October issue of Plastic and Reconstructive Surgery.
Read more about New Technique For Injectable Facial Fillers Improves Comfort, Recovery
Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis (RA) patients continue to suffer from pain. Research published in BioMed Central’s open access journal, Arthritis Research & Therapy found that inflammation is associated with heightened pain sensitivity at joint sites, whereas increased sleep problems are associated with heightened pain sensitivity at both joint and non-joint sites.
Read more about Link Between Pain Thresholds, Inflammation And Sleep Problems In Arthritis Patients
The Pharmaceutical Society of Australia (PSA) has welcomed the release of the initial draft of the National Pain Strategy. PSA National Vice President and the only pharmacy representative on to the National Pain Summit Leaders’ Meeting, Dr Lisa Nissen, said that PSA supported the intent of the draft strategy and looked forward to seeing the strategy finalised.
Read more about Pharmaceutical Society Of Australia Supports Draft National Pain Strategy
Alkermes, Inc. (NASDAQ: ALKS) announced the initiation of a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the opioid agonist effects on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).
Read more about Alkermes Announces Initiation Of Phase 1 Clinical Study Of ALKS 37 For The Treatment Of Opioid-Induced Constipation
Main Category: Pain / Anesthetics Also Included In: Pharma Industry / Biotech Industry AcelRx Pharmaceuticals, Inc announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company’s proprietary NanoTab dosage form, which enables delivery of sufentanil by the …
Read more about AcelRx Announces Successful Completion Of End-of-Phase 2 Meeting On…
Endo Pharmaceuticals Holdings Inc. filed Quarterly Report for the period ended 2009-09-30. Endo Pharmaceuticals Holdings Inc.
Read more about Endo Pharmaceuticals Holdings Inc. Reports Operating Results
